337 related articles for article (PubMed ID: 37188267)
1. Targeting the formation of estrogens for treatment of hormone dependent diseases-current status.
Rižner TL; Romano A
Front Pharmacol; 2023; 14():1155558. PubMed ID: 37188267
[TBL] [Abstract][Full Text] [Related]
2. The selective estrogen enzyme modulators in breast cancer: a review.
Pasqualini JR
Biochim Biophys Acta; 2004 Jun; 1654(2):123-43. PubMed ID: 15172700
[TBL] [Abstract][Full Text] [Related]
3. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
[TBL] [Abstract][Full Text] [Related]
4. New development in intracrinology of breast carcinoma.
Sasano H; Suzuki T; Nakata T; Moriya T
Breast Cancer; 2006; 13(2):129-36. PubMed ID: 16755106
[TBL] [Abstract][Full Text] [Related]
5. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
Smuc T; Rizner TL
Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
[TBL] [Abstract][Full Text] [Related]
6. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
[TBL] [Abstract][Full Text] [Related]
7. Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.
Hilborn E; Stål O; Jansson A
Oncotarget; 2017 May; 8(18):30552-30562. PubMed ID: 28430630
[TBL] [Abstract][Full Text] [Related]
8. Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.
Nakata T; Takashima S; Shiotsu Y; Murakata C; Ishida H; Akinaga S; Li PK; Sasano H; Suzuki T; Saeki T
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):455-60. PubMed ID: 14623544
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.
Brozic P; Lanisnik Risner T; Gobec S
Curr Med Chem; 2008; 15(2):137-50. PubMed ID: 18220769
[TBL] [Abstract][Full Text] [Related]
10. The sulfatase pathway for estrogen formation: targets for the treatment and diagnosis of hormone-associated tumors.
Secky L; Svoboda M; Klameth L; Bajna E; Hamilton G; Zeillinger R; Jäger W; Thalhammer T
J Drug Deliv; 2013; 2013():957605. PubMed ID: 23476785
[TBL] [Abstract][Full Text] [Related]
11. The Important Roles of Steroid Sulfatase and Sulfotransferases in Gynecological Diseases.
Rižner TL
Front Pharmacol; 2016; 7():30. PubMed ID: 26924986
[TBL] [Abstract][Full Text] [Related]
12. Intracrinology of estrogens and androgens in breast carcinoma.
Sasano H; Suzuki T; Miki Y; Moriya T
J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):181-5. PubMed ID: 17933521
[TBL] [Abstract][Full Text] [Related]
13. All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause.
Labrie F
J Steroid Biochem Mol Biol; 2015 Jan; 145():133-8. PubMed ID: 24923731
[TBL] [Abstract][Full Text] [Related]
14. Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers.
Purohit A; Foster PA
J Endocrinol; 2012 Feb; 212(2):99-110. PubMed ID: 21859802
[TBL] [Abstract][Full Text] [Related]
15. Advances in targeting estrogen synthesis and receptors in patients with endometriosis.
Clemenza S; Vannuccini S; Ruotolo A; Capezzuoli T; Petraglia F
Expert Opin Investig Drugs; 2022 Nov; 31(11):1227-1238. PubMed ID: 36529967
[TBL] [Abstract][Full Text] [Related]
16. Increased estrogen sulfatase (STS) and 17beta-hydroxysteroid dehydrogenase type 1(17beta-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients.
Chanplakorn N; Chanplakorn P; Suzuki T; Ono K; Chan MS; Miki Y; Saji S; Ueno T; Toi M; Sasano H
Breast Cancer Res Treat; 2010 Apr; 120(3):639-48. PubMed ID: 20151319
[TBL] [Abstract][Full Text] [Related]
17. Is intracrinology of endometriosis relevant in clinical practice? A systematic review on estrogen metabolism.
Mercorio A; Giampaolino P; Romano A; Dällenbach P; Pluchino N
Front Endocrinol (Lausanne); 2022; 13():950866. PubMed ID: 36204107
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of Aromatase in Breast, Endometrial, and Ovarian Cancers: An Overview of Therapeutic Strategies.
Manna PR; Molehin D; Ahmed AU
Prog Mol Biol Transl Sci; 2016; 144():487-537. PubMed ID: 27865465
[TBL] [Abstract][Full Text] [Related]
19. An irreversible inhibitor of 17β-hydroxysteroid dehydrogenase type 1 inhibits estradiol synthesis in human endometriosis lesions and induces regression of the non-human primate endometriosis.
Poirier D; Nyachieo A; Romano A; Roy J; Maltais R; Chai D; Delvoux B; Tomassetti C; Vanhie A
J Steroid Biochem Mol Biol; 2022 Sep; 222():106136. PubMed ID: 35691460
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of type 1 17β-hydroxysteroid dehydrogenase impairs the synthesis of 17β-estradiol in endometriosis lesions.
Delvoux B; D'Hooghe T; Kyama C; Koskimies P; Hermans RJ; Dunselman GA; Romano A
J Clin Endocrinol Metab; 2014 Jan; 99(1):276-84. PubMed ID: 24187399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
